Tadalafil Citrate Research Overview
Tadalafil citrate is a phosphodiesterase type 5 (PDE5) inhibitor developed for investigating vascular smooth muscle mechanisms and cyclic adenosine monophosphate (cAMP) pathways. This compound represents a significant advancement in cardiovascular research, offering researchers at Stroid UK Shop access to pharmaceutical-grade materials for comprehensive laboratory studies. Dragon Pharma’s formulation provides consistent molecular structure for examining endothelial function, nitric oxide signalling, and pulmonary arterial pressure dynamics in controlled research environments.
Laboratory Research Applications
Research institutions examine tadalafil citrate for its selective inhibition of phosphodiesterase enzymes, particularly PDE5 found in vascular smooth muscle tissue. Studies investigate its mechanism in blocking cGMP degradation, leading to sustained vasodilation in experimental models. Cardiovascular researchers analyse tadalafil’s extended half-life compared to sildenafil, making it valuable for long-term tissue perfusion studies. Pulmonary hypertension research explores its effects on right heart function and exercise capacity in laboratory animals. Tadalafil research compounds enable comprehensive evaluation of benign prostatic hyperplasia mechanisms, lower urinary tract function, and smooth muscle relaxation pathways in controlled laboratory protocols.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | Tadalafil Citrate |
| CAS Number | 171596-29-5 |
| Molecular Formula | C₂₂H₁₉N₃O₄·C₆H₈O₇ |
| Molecular Weight | 581.56 g/mol |
| Mechanism | PDE5 Inhibitor |
| Solubility | Aqueous solutions, DMSO |
| Storage | Room temperature, dry environment |
Dragon Pharma maintains strict quality control protocols ensuring molecular integrity throughout manufacturing processes. Research teams studying vascular biology benefit from this compound’s stability and reproducible results across experimental conditions. Advanced laboratories investigating selective androgen receptor modulators often compare PDE5 inhibition pathways with other signalling mechanisms. Similarly, peptide research frequently examines complementary vascular effects when combined with tadalafil in multi-pathway studies.
Research Compliance Statement
This tadalafil citrate preparation is manufactured exclusively for in-vitro research applications and laboratory investigations. Not intended for human consumption, therapeutic use, or clinical applications. Researchers must comply with institutional protocols and legal requirements when handling pharmaceutical research compounds. All experimental procedures should follow appropriate safety guidelines and waste disposal regulations.
